NIH / NCCIH Funding Opportunities

The following is a list of RFAs from the HEAL Initiatives, all relevant to acupuncture research: 

Notice Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)
Notice Number RFA-AT-19-005
Post Date 10-Dec-18
Expiration Date 16-Mar-19
   
Notice Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3) (Clinical Trial Optional)
Notice Number RFA-AR-19-028
Post Date 10-Dec-18
Expiration Date 21-Mar-19
   
Notice Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3) (Clinical Trial Required)
Notice Number RFA-AR-19-029
Post Date 10-Dec-18
Expiration Date 27-Feb-19
   
Notice Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19) (Clinical Trial Optional)
Notice Number RFA-AR-19-026
Post Date 10-Dec-18
Expiration Date 21-Mar-19
   
Notice Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Notice Number RFA-NS-19-016
Post Date 10-Dec-18
Expiration Date 22-Feb-21
   
Notice Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Notice Number RFA-NS-19-017
Post Date 10-Dec-18
Expiration Date 22-Feb-21
   
Notice Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Notice Number RFA-NS-19-018
Post Date 10-Dec-18
Expiration Date 22-Feb-21
   
Notice Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
Notice Number RFA-EB-18-003
Post Date 10-Dec-18
Expiration Date 23-Feb-21
   
Notice Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-046
Post Date 19-Sep-18
Expiration Date 13-Mar-20
   
Notice Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-041
Post Date 2-Aug-18
Expiration Date 13-Mar-20